unimportant decoration Nano-scale droplet illustration

About BlueWillow Biologics

unimportant decoration

BlueWillow Biologics® is a clinical-stage, privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines using its patented nanoemulsion platform. The platform, originally discovered at the University of Michigan, employs novel oil-in-water nano-droplets as an intranasal adjuvant that elicits a balanced Th1/Th17 mucosal and robust systemic immune responses.  This NanoVax® platform has established proof of concept in humans and enables intranasal vaccines for challenging respiratory infections, sexually transmitted infections and food allergies. The company’s lead candidates include intranasal vaccines for Covid-19, HSV-2, Peanut Allergy, RSV, Anthrax and pandemic influenza.